REAL-LIFE STUDY OF THE EFFICACY AND TOLERANCE OF TRAMETINIB IN THE TREATMENT OF LOW-GRADE GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1

被引：0
|
作者：
Bibollet, Amandine [1 ]
Khouri, Celine [2 ]
Abbou, Samuel [2 ]
Faure-Conter, Cecile [3 ]
Amini-Adle, Mona [4 ]
Darnis, Sophie [5 ]
Philippe, Michael [3 ]
Neumann, Florent [1 ]
Leblond, Pierre [3 ]
机构：
[1] Hop Univ F Mitterrand Dijon Bourgogne, Dept Pediat Hematol & Oncol, Dijon, France
[2] Univ Paris Saclay, Dept Pediat & Adolescent Oncol, Gustave Roussy Canc Campus, Villejuif, France
[3] Inst Pediat Hematol & Oncol IHOPe, Leon Berard Canc Ctr, Lyon, France
[4] Leon Berard Canc Ctr, Dept Dermatol, Lyon, France
[5] Leon Berard Canc Ctr, Clin Res & Innovat Dept, Lyon, France
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae064.430
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LGG-39
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study
    Jakacki, Regina I.
    Bouffet, Eric
    Adamson, Peter C.
    Pollack, Ian F.
    Ingle, Ashish M.
    Voss, Stephan D.
    Blaney, Susan M.
    NEURO-ONCOLOGY, 2011, 13 (08) : 910 - 915
  • [32] A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1
    Mahdi, Jasia
    Shah, Amish C.
    Sato, Aimee
    Morris, Stephanie M.
    McKinstry, Robert C.
    Listernick, Robert
    Packer, Roger J.
    Fisher, Michael J.
    Gutmann, David H.
    NEUROLOGY, 2017, 88 (16) : 1584 - 1589
  • [33] Changes in the intensity of pain and quality of life in patients with low-grade gliomas after surgical treatment
    Kurnukhina, M.
    Cherebillo, V.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 88 - 88
  • [34] Changes in the intensity of pain and quality of life in patients with low-grade gliomas after surgical treatment
    Kurnukhina, M.
    Cherebillo, V.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 58 - 58
  • [35] Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group
    Ater, Joann L.
    Xia, Caihong
    Mazewski, Claire M.
    Booth, Timothy N.
    Freyer, David R.
    Packer, Roger J.
    Sposto, Richard
    Vezina, Gilbert
    Pollack, Ian F.
    CANCER, 2016, 122 (12) : 1928 - 1936
  • [36] TARGETED THERAPY IN PEDIATRIC LOW-GRADE GLIOMAS; REAL WORLD DATA IN THE CONTEXT OF CONVENTIONAL TREATMENT MODALITIES
    Sumerauer, David
    Trkova, Katerina
    Benes, Vladimir
    Krskova, Lenka
    Kyncl, Martin
    Sramkova, Lucie
    Zapotocky, Michal
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [37] TARGETED THERAPY IN PEDIATRIC LOW-GRADE GLIOMAS; REAL WORLD DATA IN THE CONTEXT OF CONVENTIONAL TREATMENT MODALITIES
    Sumerauer, David
    Trkova, Katerina
    Koblizek, Miroslav
    Kyncl, Martin
    Krskova, Lenka
    Benes, Vladimir
    Zapotocky, Michal
    NEURO-ONCOLOGY, 2023, 25
  • [38] Phase II study of oral temozolomide (TMZ) in children with progressive low-grade gliomas (LGG)
    Gururangan, S
    Allen, JC
    Phillips, PC
    Dillard, E
    Friedman, HS
    NEURO-ONCOLOGY, 2004, 6 (04) : 457 - 457
  • [39] Predicting the Type of Tumor-Related Epilepsy in Patients With Low-Grade Gliomas: A Radiomics Study
    Wang, Yinyan
    Wei, Wei
    Liu, Zhenyu
    Liang, Yuchao
    Liu, Xing
    Li, Yiming
    Tang, Zhenchao
    Jiang, Tao
    Tian, Jie
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [40] LONG-TERM EFFICACY AND TOXICITY OF BEVACIZUMAB-BASED THERAPY IN CHILDREN WITH RECURRENT LOW-GRADE GLIOMAS
    Hwang, Eugene
    Jakacki, Regina
    Fisher, Michael
    Kilburn, Lindsay
    Horn, Marianna
    Vezina, Gilbert
    Rood, Brian
    Packer, Roger
    NEURO-ONCOLOGY, 2012, 14 : 69 - 69
12345